AFRM vs NRIX · P/E 590, rev $3.22B vs rev $54.5M
Affirm Holdings Inc (AFRM) versus Nurix Therapeutics Inc (NRIX) — a side-by-side from cached financials, not a winner call.
Affirm Holdings Inc (AFRM) is a software - infrastructure company listed on US.
Nurix Therapeutics Inc (NRIX) is a biotechnology company listed on NASDAQ.
Latest reported AFRM revenue for 2025-06-30 was $3.22B. Net income was $52.2M. Revenue was up 38.8% from 2024-06-30 to 2025-06-30. AFRM currently screens at market cap $28.80B and trailing P/E 589.7.
Latest reported NRIX revenue for 2024-11-30 was $54.5M. Net income was -$193.6M. Revenue was down 29.1% from 2023-11-30 to 2024-11-30. NRIX currently screens at market cap $1.77B.
AFRM currently screens at market cap $28.80B and trailing P/E 589.7. NRIX currently screens at market cap $1.77B.
Not investment advice. Open the AFRM and NRIX stock pages for the full models.
Not investment advice.